Page 111 - 2021年19期

[ 8 ] TUMBARELLO M，DE PASCALE G，TRECARICHI E M， [15] KALIN G，ALP E，COSKUN R，DEMIRASLAN H，et al.
et al. Effect of aerosolized colistin as adjunctive treatment Use of high-dose Ⅳ and aerosolized colistin for the treat-
on the outcomes of microbiologically documented ventila- ment of multidrug-resistant Acinetobacter baumannii ven-
tor-associated pneumonia caused by colistin-only suscepti- tilator-associated pneumonia：do we really need this treat-
ble Gram-negative bacteria[J]. Chest ，2013，14（4）：1768- ment[J]. J Infect Chemother，2012，18：872-877.
1775. [16] JI J Y，KWON H Y，CHOI E H，et al. Efficacy and toxici-
[ 9 ] RATTANAUMPAWAN P，LORSUTTHITHAM J， ty of high-dose nebulized colistin for critically ill surgical
UNGPRASERT P，et al. Randomized controlled trial of patients with ventilator-associated pneumonia caused by
nebulized colistimethate sodium as adjunctive therapy of multidrug-resistant Acinetobacter baumannii[J]. J Critical
ventilator-associated pneumonia caused by Gram-negative Care，2017，40：251-256.
bacteria[J]. J Antimicrob Chemother，2010，6（5）：2645- [17] BOGOVIĆ T Z，BUDIMIR A，BOŠNJAKZ，et al. Inhala-
2649. tion plus intravenous colistin versus intravenous colistin
[10] POLAT M，KARA S S，TAPISIZ A，et al. Treatment of alone for treatment of ventilator associated pneumonia[J].
ventilator-associated pneumonia using intravenous colis- Signa Vitae，2014，9：29-33.
tin alone or in combination with inhaled colistin in critical- [18] ABDELLATIF S，TRIFI A，DALY F，et al. Efficacy and
ly ill children[J]. Pediatric Drugs，2015，17（4）：1-8 . toxicity of aerosolized colistin in ventilator-associated
[11] PÉREZ-PEDRERO M J，SÁNCHEZ-CASADO M， pneumonia：a prospective，randomised trial[J]. Ann Inten-
RODRÍGUEZ V S，et al. Nebulized colistin treatment of sive Care，2016，6（1）：26.
multi-resistant Acinetobacter baumannii pulmonary infec- [19] MOHAMED A，ALAA R，ASSEM F，et al. Re-emerging
tion in critical ill patients[J]. Med Intensiva，2011，3（5）： of colistin for treatment of nosocomial pneumonia due to
226-231. gram negative multi-drug resistant pathogens in critically
[12] NAESENS R，VLIEGHE E，VERBRUGGHE W，et al. A ill patients[J]. Egyptian Journal of Chest Diseases and
retrospective observational study on the efficacy of colis- Tuberculosis，2013，62 ：447-451.
tin by inhalation as compared to parenteral administration [20] KWA A L，LOH C，LOW J G，et al. Nebulized colistin in
for the treatment of nosocomial pneumonia associated the treatment of pneumonia due to multidrug-resistant Aci-
with multidrug-resistant Pseudomonas aeruginosa[J]. netobacter baumannii and Pseudomonas aeruginosa[J].
BMC Infect Dis，2011，11，317-325. Clin Infect Dis，2005，41（5）：754.
[13] KORBILA I P，MICHALOPOULOS A，RAFAILIDIS P I， [21] LESHO E. Role of inhaled antibacterials in hospital-ac-
et al. Inhaled colistin as adjunctive therapy to intravenous quired and ventilator-associated pneumonia[J]. Expert
colistin for the treatment of microbiologically documented Rev Anti Infect Ther，2005，3（3）：445.
ventilator-associated pneumonia：a comparative cohort [22] RELLO J，ROUBY J J，SOLE-L C，et al. Key considera-
study[J]. Clin Microbiol Infect ，2010，16：1230-1236. tions on nebulization of antimicrobial agents to mechani-
[14] KOFTERIDIS DP，ALEXOPOULOU C，VALACHIS A， cally ventilated patients[J]. Clin Microbiol Infect，2017，23
et al. Aerosolized plus intravenous colistin versus intrave- （9）：640.
nous colistin alone for the treatment of ventilator-associa- （收稿日期：2021-04-19 修回日期：2021-06-24）
ted pneumonia：a matched case-control study[J]. Clin （编辑：刘明伟）
Infect Dis，2010，51（11）：1238-1244 .

《中国药房》杂志——RCCSE中国核心学术期刊，欢迎投稿、订阅

中国药房 2021年第32卷第19期 China Pharmacy 2021 Vol. 32 No. 19 ·2405 ·